Korean Journal of Clinical Oncology impact factor (publications and citations) | exaly Search Engine
Systemic Management of iCCA: Role of Molecular Therapies - ppt download
Systemic Management of iCCA: Role of Molecular Therapies - ppt download
Journals | ONS
Annals of Clinical Oncology | Journal Science Repository | Open Access
Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy? | Journal of Clinical Oncology
Risk-Imaging Mismatch: Why Is There a Disconnect? | Journal of Clinical Oncology
International Journal of Clinical Oncology 6/2018 | springermedizin.de
Journal of Clinical Oncology on Twitter: "Trastuzumab and docetaxel in HER2-positive salivary duct carcinoma https://t.co/NOmMm07JqO https://t.co/2th6T5QlHd" / Twitter
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges | Nature Reviews Clinical Oncology
Educating undergraduate medical students about oncology. a literature…
Journal of Clinical Oncology :
Journal of Clinical Oncology on Twitter: "Intraperitoneal and IV paclitaxel + S-1 versus cisplatin + S-1 in gastric cancer with peritoneal metastases https://t.co/DOMDsog98i #stcsm https://t.co/5Q7pI9WGMo" / Twitter
Archives | Oncology Journal | Open Access Cancer Research
Harborside • The Nexus of Knowledge
Journal of Clinical Oncology :
Volume 15 | Nature Reviews Clinical Oncology
Session Chairs - 2018 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Volume 15 | Nature Reviews Clinical Oncology
ASCO 2018 Abstracts Released — All 650 Pages Worth! - Cancer Health
Home | Cancer and Clinical Oncology | CCSE
Clinical Oncology - Journal - Elsevier
Journal of Clinical Oncology and Cancer Research | Aim and Scope
PDF) Study protocol for J-SUPPORT 1604 (J-FORCE): A randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting
Asia-Pacific Journal of Clinical Oncology: Vol 14, No 6
Clinical & Experimental Oncology- High Impact Factor Journal
Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies | Journal of Clinical Oncology
